Fungicip 150

Fungicip 150

  • Brand: Cipla, India
  • Product Code: Fungicip 150
  • Availability: In Stock
  • $2.00



Manufacturer: Cipla, India
Pharmaceutical name: Fluconazole
Pack: 1 pill (150 mg)
Fungicip is utilized to combat the fungal infection caused by candida and its associated pathologies. One of the key benefits of Fungicip is its rapid effectiveness; however, if the infection is overlooked, patients may need to use Fungicip intermittently during frequent bouts of thrush. A significant advantage of Fungicip is that it can be administered even before the causative agent of the infection is identified.
 
Fungicip is deemed safe for use in patients with oncological diseases and AIDS. Its use in pediatric cases is permissible, but any medicinal treatment should occur under the supervision of a healthcare professional.
 
The primary active ingredient in Fungicip is Fluconazole. The mechanism of action for Fungicip involves inhibiting the synthesis of sterols within fungal cells, which affects their cell membranes by increasing permeability. Consequently, this leads to a reduction in the growth and replication of the affected cells.
 
Fluconazole effectively prevents the progression of various fungal infections, including generalized candidiasis, particularly in immunocompromised patients. Due to its rapid pharmacological effects, patients often experience relief, with all symptoms of severe fungal infections subsiding.
 
Fungicip should be continued until all clinical symptoms have completely resolved. Each patient receives a personalized dosage based on their age and the type of fungal infection. For genital candidiasis, a single tablet of Fungicip is recommended. To prevent vaginal candidiasis, Fungicip should be taken once monthly at a dosage of 150 mg over a 6-month period. For mycosis, the typical prescription is 150 mg weekly for 1-2 months. In cases of severe fungal infections, the dosage may be adjusted to 50 mg daily for 2-4 weeks. The maximum permissible daily dose of Fungicip is 400 mg, but such high doses must be given under medical supervision in line with clinical guidelines.
 
In cases of recurrent candidiasis, Fungicip may be taken until the complete eradication of the infectious agents and alleviation of symptoms.
 
Occasionally, the use of Fungicip may lead to side effects. The most commonly reported side effects include headaches, muscle cramps, dyspepsia, and dizziness. These side effects generally occur during the initial days of treatment and typically do not require medical intervention.
 
If more severe side effects arise, such as liver dysfunction or allergic reactions, it is crucial to notify a healthcare provider. In such cases, it may be necessary to lower the daily dosage or replace Fungicip with an alternative medication containing a different active ingredient.